3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
19
Neoplasms
12
Colorectal Neoplasms
5
Pain, Postoperative
4
Fatigue
4
Thyroid Neoplasms
3
Stomatitis
3
Pain
3
Malnutrition
3
Liver Neoplasms
3
Depression
3
Carcinoma, Hepatocellular
3
Anxiety Disorders
3
Stomach Neoplasms
2
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Motor Activity
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Cancer Female
2
Agnosia
2
Weight Loss
1
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Incontinence
1
Unilateral U/S PVB
1
Ulcer
1
Interventions
Docetaxel
158
Prednisone
131
Leuprolide
95
bicalutamide
86
enzalutamide
83
Radiotherapy
80
Goserelin
80
Abiraterone Acetate
76
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
54
Magnetic Resonance Spectroscopy
46
Zoledronic Acid
44
gallium 68 PSMA-11
37
Flutamide
34
abiraterone
32
Estramustine
32
radium Ra 223 dichloride
30
apalutamide
27
Surveys and Questionnaires
26
Gonadotropin-Releasing Hormone
26
Androgen Antagonists
25
cabazitaxel
24
Radiosurgery
24
Dutasteride
22
sipuleucel-T
21
Prednisolone
21
Triptorelin Pamoate
20
Paclitaxel
20
luprolide acetate gel depot
19
Radiation
19
Exercise
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms
×
Control Groups
×
Clear all
NCT04862533
2022-12-16
BELA
University Hospital Olomouc
Phase NA
Completed
80 enrolled